| __timestamp | Amphastar Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 520990000000 |
| Thursday, January 1, 2015 | 174172000 | 535405000000 |
| Friday, January 1, 2016 | 150976000 | 558755000000 |
| Sunday, January 1, 2017 | 149380000 | 495921000000 |
| Monday, January 1, 2018 | 187681000 | 659690000000 |
| Tuesday, January 1, 2019 | 190434000 | 1089764000000 |
| Wednesday, January 1, 2020 | 206506000 | 994308000000 |
| Friday, January 1, 2021 | 238029000 | 1106846000000 |
| Saturday, January 1, 2022 | 250127000 | 1244072000000 |
| Sunday, January 1, 2023 | 293274000 | 1431505000000 |
| Monday, January 1, 2024 | 1431505000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis delves into the cost of revenue trends for Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Takeda's cost of revenue surged by approximately 175%, peaking at 1.43 trillion in 2023. This reflects its expansive growth and strategic acquisitions. In contrast, Amphastar's cost of revenue increased by about 84% during the same period, reaching 293 million in 2023. This steady rise underscores its focus on niche markets and efficient operations. Notably, 2024 data for Amphastar is missing, indicating potential reporting delays or strategic shifts. As these companies navigate the complexities of global healthcare, their cost management strategies will be pivotal in maintaining competitive edges and driving future growth.
"Cost of Revenue Trends: Takeda vs. Amphastar Over a Decade"
Cost Insights: Breaking Down Eli Lilly and Company and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: AstraZeneca PLC vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Takeda Pharmaceutical Company Limited vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Cost Insights: Breaking Down Grifols, S.A. and Amphastar Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.